Gene editing of DNAH11 restores normal cilia motility in primary ciliary dyskinesia M Lai, M Pifferi, A Bush, M Piras, A Michelucci, M Di Cicco, A Del Grosso, ... Journal of medical genetics 53 (4), 242-249, 2016 | 70 | 2016 |
The combination of four molecular markers improves thyroid cancer cytologic diagnosis and patient management F Panebianco, C Mazzanti, S Tomei, P Aretini, S Franceschi, F Lessi, ... Bmc Cancer 15, 1-11, 2015 | 57 | 2015 |
CXCL 12α/SDF‐1 from perisynaptic Schwann cells promotes regeneration of injured motor axon terminals S Negro, F Lessi, E Duregotti, P Aretini, M La Ferla, S Franceschi, ... EMBO molecular medicine 9 (8), 1000-1010, 2017 | 56 | 2017 |
Laser capture microdissection and RNA-seq analysis: High sensitivity approaches to explain histopathological heterogeneity in human glioblastoma FFPE archived tissues P Civita, S Franceschi, P Aretini, V Ortenzi, M Menicagli, F Lessi, ... Frontiers in oncology 9, 482, 2019 | 52 | 2019 |
Human saliva as route of inter-human infection for mouse mammary tumor virus CM Mazzanti, F Lessi, I Armogida, K Zavaglia, S Franceschi, M Al Hamad, ... Oncotarget 6 (21), 18355, 2015 | 47 | 2015 |
Micro-RNA-21 (biomarker) and global longitudinal strain (functional marker) in detection of myocardial fibrotic burden in severe aortic valve stenosis: a pilot study I Fabiani, C Scatena, CM Mazzanti, L Conte, NR Pugliese, S Franceschi, ... Journal of translational medicine 14, 1-11, 2016 | 45 | 2016 |
Whole-exome analysis in osteosarcoma to identify a personalized therapy C Chiappetta, M Mancini, F Lessi, P Aretini, V De Gregorio, C Puggioni, ... Oncotarget 8 (46), 80416, 2017 | 43 | 2017 |
Serotonin depletion causes valproate-responsive manic-like condition and increased hippocampal neuroplasticity that are reversed by stress G Maddaloni, S Migliarini, F Napolitano, A Giorgi, S Nazzi, D Biasci, ... Scientific Reports 8 (1), 11847, 2018 | 33 | 2018 |
Molecular characterization of low grade and high grade bladder cancer A Apollo, V Ortenzi, C Scatena, K Zavaglia, P Aretini, F Lessi, ... PLoS One 14 (1), e0210635, 2019 | 29 | 2019 |
Mitochondrial enzyme GLUD2 plays a critical role in glioblastoma progression S Franceschi, D Corsinovi, F Lessi, E Tantillo, P Aretini, M Menicagli, ... EBioMedicine 37, 56-67, 2018 | 26 | 2018 |
Investigating molecular alterations to profile short-and long-term recurrence-free survival in patients with primary glioblastoma S Franceschi, CM Mazzanti, F Lessi, P Aretini, FG Carbone, M La Ferla, ... Oncology Letters 10 (6), 3599-3606, 2015 | 25 | 2015 |
Loss of c-KIT expression in thyroid cancer cells S Franceschi, F Lessi, F Panebianco, E Tantillo, M La Ferla, M Menicagli, ... PloS one 12 (3), e0173913, 2017 | 21 | 2017 |
Molecular portrait of a rare case of metastatic glioblastoma: somatic and germline mutations using whole-exome sequencing S Franceschi, F Lessi, P Aretini, CM Mazzanti, M Menicagli, M La Ferla, ... Neuro-oncology 18 (2), 298-300, 2016 | 19 | 2016 |
Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early M Morelli, F Lessi, S Barachini, R Liotti, N Montemurro, P Perrini, ... Frontiers in oncology 12, 969812, 2022 | 18 | 2022 |
Next generation sequencing technologies for a successful diagnosis in a cold case of Leigh syndrome P Aretini, CM Mazzanti, M La Ferla, S Franceschi, F Lessi, V De Gregorio, ... BMC neurology 18, 1-6, 2018 | 18 | 2018 |
A new immunization and treatment strategy for mouse mammary tumor virus (MMTV) associated cancers O Braitbard, M Roniger, A Bar-Sinai, D Rajchman, T Gross, ... Oncotarget 7 (16), 21168, 2016 | 15 | 2016 |
Association between RAD 51 rs1801320 and susceptibility to glioblastoma S Franceschi, S Tomei, CM Mazzanti, F Lessi, P Aretini, M La Ferla, ... Journal of neuro-oncology 126, 265-270, 2016 | 15 | 2016 |
Molecular profiling of microinvasive breast cancer microenvironment progression F Lessi, C Scatena, P Aretini, M Menicagli, S Franceschi, AG Naccarato, ... Journal of Translational Medicine 17, 1-13, 2019 | 12 | 2019 |
ANKRD44 gene silencing: a putative role in trastuzumab resistance in Her2-like breast cancer M La Ferla, F Lessi, P Aretini, D Pellegrini, S Franceschi, E Tantillo, ... Frontiers in Oncology 9, 547, 2019 | 12 | 2019 |
Association of Glutathione S-Transferase P-1 (GSTP-1) rs1695 polymorphism with overall survival in glioblastoma patients treated with combined radio … F Pasqualetti, A Gonnelli, M Cantarella, D Delishaj, A Molinari, V Ortenzi, ... Investigational new drugs 36, 340-345, 2018 | 12 | 2018 |